Skip to contentE
Electromedical Technologies, Inc
E
EMEDElectromedical Technologies, Inc Q3 2023 · 10-Q
Revenue$323.61K$323.61K+15.8% vs Q3 2022 Net Income-$376.72K-$376.72KN/M vs Q3 2022 EPS Diluted$0.00$0.00N/M vs Q3 2022 Gross Profit$251,176+13.4% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Electromedical Technologies, Inc · CIK 1715819 · Engraved from SEC EDGAR
Operating Cash Flowderived-$277,779N/M Free Cash Flowderived-$277,779— Margins · derivedGross margin77.6%−1.6 pt vs Q3 2022
Operating margin-73.9%+46.8 pt vs Q3 2022
Net margin-116.4%+226.3 pt vs Q3 2022
ended Sep 30, 2023 · filed Nov 20, 2023 · 51 d after period end